PCN37 Cost Comparison of Erlotinib Versus Generic Docetaxel in Second-Line Non-Small Cell Lung Cancer in Italy
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1154
https://www.valueinhealthjournal.com/article/S1098-3015(12)01219-3/fulltext
Title :
PCN37 Cost Comparison of Erlotinib Versus Generic Docetaxel in Second-Line Non-Small Cell Lung Cancer in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01219-3&doi=10.1016/j.jval.2012.03.1154
First page :
A214
Section Title :
Cancer
Open access? :
No
Section Order :
677